How many stocks are there of Organo?
The current number of stocks of Organo is 45.93 M undefined.
Organo Stocks 2024
Organo Stocks
45.93 M
Ticker
6368.T
ISIN
JP3201600008
In 2024, Organo had 45.93 M outstanding stocks, a 0.14% change from the 45.86 M stocks in the previous year.
The Organo Stocks history
| YEAR | NUMBER OF STOCKS (undefined JPY) |
|---|---|
| 2027e | 45.93 |
| 2026e | 45.93 |
| 2025e | 45.93 |
| 2024 | 45.93 |
| 2023 | 45.86 |
| 2022 | 45.9 |
| 2021 | 45.88 |
| 2020 | 45.76 |
| 2019 | 45.84 |
| 2018 | 46.05 |
| 2017 | 46.06 |
| 2016 | 11.52 |
| 2015 | 11.52 |
| 2014 | 12 |
| 2013 | 12 |
| 2012 | 12 |
| 2011 | 12 |
| 2010 | 12 |
| 2009 | 12 |
| 2008 | 12 |
| 2007 | 12 |
| 2006 | 12 |
| 2005 | 12 |
Organo shares outstanding JP3201600008 ·
The number of shares was Organo in 2023 — This indicates how many shares 45.863 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Organo earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Organo's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Organo’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Organo's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2005 | 12 M Aktien |
| 2006 | 12 M Aktien |
| 2007 | 12 M Aktien |
| 2008 | 12 M Aktien |
| 2009 | 12 M Aktien |
| 2010 | 12 M Aktien |
| 2011 | 12 M Aktien |
| 2012 | 12 M Aktien |
| 2013 | 12 M Aktien |
| 2014 | 12 M Aktien |
| 2015 | 11.52 M Aktien |
| 2016 | 11.52 M Aktien |
| 2017 | 46.06 M Aktien |
| 2018 | 46.05 M Aktien |
| 2019 | 45.84 M Aktien |
| 2020 | 45.76 M Aktien |
| 2021 | 45.88 M Aktien |
| 2022 | 45.9 M Aktien |
| 2023 | 45.86 M Aktien |
| 2024 | 45.93 M Aktien |
| 2025e | 45.93 M Aktien |
| 2026e | 45.93 M Aktien |
| 2027e | 45.93 M Aktien |
Organo Aktienanalyse
What does Organo do?
Organo Corp is an internationally operating company specialized in the production and distribution of products in the health and wellness industry. The company was founded in Vancouver, Canada in 2008 by Bernardo Chua. Organo Corp's business model is based on network marketing to sell its products. This has allowed the company to quickly build a large customer base and become active in over 50 countries. The goal of Organo Corp is to help every customer lead a healthier and happier life. Organo Corp is divided into different divisions to offer customers a wide range of products. One of the main divisions is "Organo Gold," which offers coffee and tea products. These products are based on traditional Asian herbs and fungi such as Reishi, Ganoderma, and Cordyceps. These herbs have many active ingredients that strengthen the immune system, increase energy levels, reduce stress, and promote overall well-being. Another division of Organo Corp is "Organo Essentials," which offers products for a healthy everyday life. This includes supplements such as multivitamin tablets, protein powder, and Omega-3 fatty acids. These supplements are made from high-quality ingredients and aim to improve overall well-being. Organo Corp also has a "Personal Care" division, which offers products for personal hygiene. These include soaps, shampoos, creams, and lotions. These products contain natural ingredients such as tea tree oil, aloe vera, shea butter, and various essential oils that are intended to nourish and protect the skin. The company also has an "Organo Graphics" division, which offers marketing materials to help independent distributors of Organo Corp build their own business. This includes brochures, business cards, and sales tools. Organo Corp has also made a name for itself through various philanthropic activities. The company has established the "OG Care Foundation," which advocates for disadvantaged children and their families worldwide. The foundation supports projects in the areas of education, health, and well-being. In summary, Organo Corp is a company specializing in the sale of products in the health and wellness industry. The company offers a wide range of products based on natural ingredients such as Asian herbs and fungi. Through network marketing, Organo Corp has quickly built a large customer base and is now active in over 50 countries. Additionally, the company is committed to supporting disadvantaged children around the world through the "OG Care Foundation." Organo ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Organo's Shares Outstanding
Organo's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Organo’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Organo’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Organo’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Organo stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Organo are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Organo evolved in recent years?
The number of shares of Organo has increased by 0.14% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Organo as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Organo?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Organo pay?
Over the past 12 months, Organo paid a dividend of 114 JPY . This corresponds to a dividend yield of about 1.85 %. For the coming 12 months, Organo is expected to pay a dividend of 118.51 JPY.
What is the dividend yield of Organo?
The current dividend yield of Organo is 1.85 %.
When does Organo pay dividends?
Organo pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Organo?
Organo paid dividends every year for the past 23 years.
What is the dividend of Organo?
For the upcoming 12 months, dividends amounting to 118.51 JPY are expected. This corresponds to a dividend yield of 1.92 %.
In which sector is Organo located?
Organo is assigned to the 'Industry' sector.
Wann musste ich die Aktien von Organo kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Organo from 12/1/2024 amounting to 53 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did Organo pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of Organo in the year 2023?
In the year 2023, Organo distributed 74 JPY as dividends.
In which currency does Organo pay out the dividend?
The dividends of Organo are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Organo
Our stock analysis for Organo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Organo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
